- Report
- February 2026
- 250 Pages
Global
From €4015EUR$4,490USD£3,466GBP
- Report
- February 2026
- 250 Pages
Global
From €4015EUR$4,490USD£3,466GBP
- Report
- February 2026
- 250 Pages
Global
From €4015EUR$4,490USD£3,466GBP
- Report
- February 2026
- 250 Pages
Global
From €4015EUR$4,490USD£3,466GBP
- Report
- February 2026
- 250 Pages
Global
From €4015EUR$4,490USD£3,466GBP
- Report
- June 2026
- 282 Pages
Global
From €5231EUR$5,850USD£4,515GBP
- Report
- November 2025
- 119 Pages
Global
From €3500EUR$4,193USD£3,127GBP
- Report
- July 2025
- 132 Pages
Global
From €4337EUR$4,850USD£3,744GBP
- Report
- February 2026
- 195 Pages
Global
From €4337EUR$4,850USD£3,744GBP
- Report
- September 2025
- 150 Pages
Global
From €4337EUR$4,850USD£3,744GBP
- Report
- August 2025
- 200 Pages
United States
From €2226EUR$2,490USD£1,922GBP
- Report
- July 2025
- 120 Pages
United States
From €5320EUR$5,950USD£4,593GBP
- Report
- November 2025
- 130 Pages
Middle East
From €5320EUR$5,950USD£4,593GBP
- Report
- March 2025
- 309 Pages
Global
From €4023EUR$4,499USD£3,473GBP
- Report
- May 2025
- 560 Pages
Global
From €4426EUR$4,950USD£3,821GBP
- Drug Pipelines
- March 2022
- 900 Pages
Global
From €8047EUR$9,000USD£6,947GBP
- Report
- November 2022
- 295 Pages
Global
From €4426EUR$4,950USD£3,821GBP
- Report
- December 2022
- 260 Pages
Global
From €2146EUR$2,400USD£1,852GBP
- Report
- June 2023
- 186 Pages
Global
From €4158EUR$4,650USD£3,589GBP
- Report
- March 2021
- 216 Pages
Global
From €2459EUR$2,750USD£2,123GBP

Biomarkers are biological molecules that can be used to measure the presence or absence of a disease, such as cancer. Cancer markers are a type of biomarker that can be used to detect the presence of cancer in a patient. They can be used to diagnose, monitor, and predict the progression of cancer. Cancer markers can be proteins, hormones, enzymes, or other molecules that are produced by cancer cells or are associated with the presence of cancer.
Cancer markers are used in a variety of ways, including to detect the presence of cancer, to monitor the progression of the disease, and to predict the response to treatment. They can also be used to identify patients who are at risk for developing cancer.
The cancer marker market is a rapidly growing segment of the biomarker market. It is driven by the increasing prevalence of cancer, the development of new technologies for detecting and monitoring cancer, and the increasing demand for personalized medicine.
Companies in the cancer marker market include Abbott Laboratories, Agilent Technologies, Becton Dickinson, Bio-Rad Laboratories, Cepheid, and Roche Diagnostics. Show Less Read more